Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07468760

Peri-Implant Hard and Soft Tissue Changes After Immediate Implant Placement With Socket Shield and Immediate Restoration Versus Early Implant Placement in the Esthetic Zone

This randomized controlled clinical trial aims to compare peri-implant hard and soft tissue dimensional changes following immediate implant placement with the socket shield technique and immediate restoration versus early type II implant placement with contour graft in the esthetic zone. The primary outcome is the Pink Esthetic Score (PES), while secondary outcomes include mid-facial mucosal recession, radiographic vertical and horizontal buccal bone remodeling, and patient satisfaction after 12 months.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gulf Medical University

Ajman, 4184, United Arab Emirates

Location contact

Mohamed Atef Sayed, Ph.D.

CONTACT

[email protected]

+971581069908 ext. 1441

Mohamed Atef Sayed, Ph.D.

SUB_INVESTIGATOR

Moheb Silwadi, M.D.S

PRINCIPAL_INVESTIGATOR

About this study

Immediate implant placement is widely used for replacing non-restorable teeth in the esthetic zone. However, post-extraction remodeling of the buccal bone plate can lead to soft tissue recession and compromised esthetic outcomes. The socket shield technique has been proposed as a partial extraction therapy designed to preserve the buccal root fragment and maintain the facial bone and gingival architecture.

This single-center, prospective randomized controlled clinical trial aims to evaluate the effectiveness of the socket shield technique with immediate implant placement and immediate restoration compared with early type II implant placement with contour augmentation.

Forty-two patients requiring extraction of a single non-restorable tooth in the esthetic zone will be randomly allocated into two groups:

Test group: Immediate implant placement with socket shield technique and immediate restoration.

Control group: Early implant placement following soft tissue healing with contour augmentation.

Clinical, radiographic, and patient-reported outcomes will be assessed over a 12-month follow-up period.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years or older
  • Patients presenting with a single non-restorable tooth in the esthetic zone indicated for extraction and implant replacement
  • Presence of a thin buccal bone plate (<1 mm)
  • Adequate bone volume to allow implant placement in a prosthetically ideal position
  • Intact socket walls following tooth extraction
  • Ability to achieve primary implant stability ≥35 Ncm at the time of implant placement
  • Patients willing to participate in the study and able to provide written informed consent

Exclusion criteria

  • History of systemic diseases that may affect bone healing
  • Use of medications that may influence bone metabolism (e.g., bisphosphonates)
  • Smoking within the past 5 years
  • Presence of acute infection at the surgical site or adjacent teeth
  • Teeth with vertical or subcrestal horizontal root fractures on the buccal aspect
  • Presence of internal or external root resorption
  • Severe periodontal destruction at the implant site

Treatment and study plan

Socket Shield

Procedure

mmediate implant placement following partial extraction therapy using the socket shield technique. After decoronation and preparation of the buccal root fragment, the implant osteotomy will be created palatal to the retained root fragment to achieve correct prosthetic positioning. The gap between the implant and the root fragment will be filled with deproteinized bovine bone mineral, and an immediate provisional restoration will be placed using a PMMA temporary crown. Final implant-supported restoration will be delivered after approximately 3 months

Other names: Partial Extraction Therapy

Early Implant Placement

Procedure

atraumatic extraction of the non-restorable tooth followed by early type II implant placement after a healing period of approximately 4-8 weeks. During implant surgery, a full-thickness flap will be elevated and the implant will be placed in the ideal prosthetic position. Contour augmentation will be performed using autogenous bone chips and deproteinized bovine bone mineral particles, which will be covered with a collagen membrane. After approximately 3 months of healing, the implant will be restored with a definitive implant-supported prosthetic restoration

Other names: Type II Implant Placement

Primary outcomes

  1. Pink Esthetic Score (PES)

    Time frame: 12 months after implant restoration

    Evaluation of peri-implant soft tissue esthetic outcome using the Pink Esthetic Score, which assesses seven parameters including mesial papilla, distal papilla, soft tissue level, soft tissue contour, alveolar process deficiency, soft tissue color, and texture around the implant restoration. Each parameter is scored from 0 to 2, with a maximum score of 14 indicating optimal esthetic outcome.

Secondary outcomes

  1. Peri-implant Mid-facial Mucosal Recession

    Time frame: 12 months after implant placement

    Measurement of vertical changes in the mid-facial peri-implant mucosal level. Digital intraoral scans obtained at baseline and during follow-up will be superimposed using digital analysis software to quantify the vertical displacement of the facial mucosal zenith relative to the baseline position.

  2. Horizontal Radiographic Peri-implant Bone Changes

    Time frame: 12 months after implant Restoration

    Assessment of horizontal dimensional changes of the buccal peri-implant bone using cone beam computed tomography (CBCT). The horizontal distance between the implant surface and the outer surface of the buccal bone plate will be measured at the mid-buccal aspect 1 mm apical to the buccal bone crest. Measurements obtained immediately after implant placement will be compared with those obtained at follow-up to determine peri-implant bone remodeling.

  3. Vertical Radiographic Peri-implant Bone Changes

    Time frame: 12 months after implant Restoration

    Assessment of vertical dimensional changes of the buccal peri-implant bone using cone beam computed tomography (CBCT). The vertical distance between the implant platform and the buccal alveolar crest at the mid-buccal aspect of the implant will be measured. Measurements obtained immediately after implant placement will be compared with those obtained at follow-up to determine vertical peri-implant bone remodeling.

  4. Patient Satisfaction

    Time frame: 12 months after implant restoration

    Patient-reported satisfaction with the implant treatment will be assessed using a Visual Analog Scale (VAS) questionnaire evaluating esthetics and functional outcomes of the implant-supported restoration. The VAS ranges from 0 to 10, where higher scores indicate greater patient satisfaction.

Study contacts

Contact information is provided by the study sponsor or research team.

Mohamed Atef Sayed, Ph.D

CONTACT

[email protected]

+971581069908 ext. 1441

Sponsors and collaborators

Lead sponsor

Gulf Medical University

Other

Registry information

Official study title

Evaluation of Peri-implant Hard And Soft Tissues Changes Between Immediate Implant Placement With Socket Shield Technique and Immediate Restoration Versus Early Type II Implant Placement in The Esthetic Zone - A Randomized Controlled Clinical Trial

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 13, 2026
Registry last updated
Mar 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.